Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 3;12(10):e0132524.
doi: 10.1128/spectrum.01325-24. Epub 2024 Sep 9.

Flagellum-deficient Pseudomonas aeruginosa is more virulent than non-motile but flagellated mutants in a cystic fibrosis mouse model

Affiliations

Flagellum-deficient Pseudomonas aeruginosa is more virulent than non-motile but flagellated mutants in a cystic fibrosis mouse model

Dina A Moustafa et al. Microbiol Spectr. .

Abstract

Loss of the flagellum marks the pathoadaptation of Pseudomonas aeruginosa to the cystic fibrosis (CF) airway environment during lung disease. Losing the flagellum is advantageous to the bacterium as the flagellum can be recognized by immune cells. The primary purpose of the flagellum is, however, to provide motility to the bacterium. Our goal was to determine whether the loss of flagellar motility or the loss of flagellum expression contributes to P. aeruginosa lung infection in CF. To address this, wild-type and gut-corrected FABP-human cystic fibrosis transmembrane conductance regulator (hCFTR) mice deficient in the murine Cftr gene were infected intratracheally with lethal doses of wild-type or flagellum-deficient P. aeruginosa. While there was no significant difference in the survival of wild-type mice after infection with either of the bacterial strains, a significantly higher mortality was observed in FABP-hCFTR mice infected with flagellum-deficient P. aeruginosa, compared to mice infected with their flagellated counterparts. When FABP-hCFTR mice were infected with isogenic, motility-deficient flagellated mutants, animal survival and lung bacterial titers were similar to those observed in mice infected with the wild-type bacterium. Airway levels of neutrophils and the amount neutrophil elastase were similar in mice infected with either the wild-type bacteria or the flagellum-deficient P. aeruginosa. Our results show that FABP-hCFTR mice have a different response to flagellum loss in P. aeruginosa compared to wild-type animals. The loss of flagellum expression, rather than the loss of motility, is the main driver behind the increased virulence of flagellum-deficient P. aeruginosa in CF. These observations provide new insight into P. aeruginosa virulence in CF.IMPORTANCEPseudomonas aeruginosa, a major respiratory pathogen in cystic fibrosis, is known to lose its flagellum during the course of infection in the airways. Here, we show that the loss of flagellum leads to a more enhanced virulence in Cftr-deficient cystic fibrosis mice than in control animals. Loss of flagellum expression, rather than the loss of flagellar swimming motility, represents the main driver behind this increased virulence suggesting that this appendage plays a specific role in P. aeruginosa virulence in cystic fibrosis airways.

Keywords: Pseudomonas aeruginosa; cystic fibrosis; flagellum; infection; inflammation; motility; neutrophil; neutrophil elastase.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIG 1
FIG 1
The lack of a flagellum increases P. aeruginosa virulence in FABP-hCFTR mice. (A) FABP-hCFTR (n = 15) and (B) WT littermate mice (n = 20) were infected intratracheally with a low dose (1.2–1.5 × 106 CFU/mouse) or high dose (~2.5×106 CFU/mouse) of P. aeruginosa PAK or PAK flgC strains and were monitored for survival for 4 days. Results are presented by Kaplan–Meier survival curves and were analyzed by log-rank test. *P < 0.05; **P < 0.01. ns, nonsignificant.
FIG 2
FIG 2
Loss of flagellum expression, not the loss of swimming motility, is the main contributor to increased virulence of flagellum-deficient P. aeruginosa in FABP-hCFTR mice. FABP-hCFTR mice (n = 9) were infected intratracheally with a low dose (1.2–1.5 × 106 CFU/mouse) or a high dose (~2.5×106 CFU/mouse) of P. aeruginosa PAK or indicated isogenic mutants and were monitored for survival for 4 days. Results are presented by Kaplan–Meier survival curves and were analyzed by log-rank test. *P < 0.05; **P < 0.01.
FIG 3
FIG 3
Loss of flagellum expression leads to increased P. aeruginosa lung burden in FABP-hCFTR mice. FABP-hCFTR mice (n = 9) were infected intratracheally with the low dose (1.2–1.5 × 106 CFU/mouse) of P. aeruginosa PAK or indicated isogenic mutants. Bacterial loads in the lungs were assessed 18 h post-infection. All samples were plated for viable CFU on Pseudomonas isolation agar. Each point represents a single mouse. Data were analyzed by one-way ANOVA and were compared using Kruskal–Wallis test for significance. *P < 0.05; **P < 0.01; ***P < 0.001. Error bars represent the mean and SEM. The dashed line represents the limit of detection (LOD).
FIG 4
FIG 4
Bacterial flagellum does not affect airway levels of neutrophils or NE in P. aeruginosa-infected FABP-hCFTR mice. FABP-hCFTR mice (n = 4–12) were infected intratracheally with low dose (1.2–1.5 × 106 CFU/mouse) of P. aeruginosa PAK or indicated isogenic mutants. The percentage of neutrophils and the amount of NE in the BAL were assessed 18 h post-infection in surviving animals by flow cytometry or ELISA, respectively. Each point represents a single animal. Data were analyzed by one-way ANOVA and Tukey’s multiple comparison test. *P < 0.05; **P < 0.01. Mean of each data set is shown..

References

    1. Vidaillac C, Chotirmall SH. 2021. Pseudomonas aeruginosa in bronchiectasis: infection, inflammation, and therapies. Expert Rev Respir Med 15:649–662. doi:10.1080/17476348.2021.1906225 - DOI - PubMed
    1. Greenwald MA, Wolfgang MC. 2022. The changing landscape of the cystic fibrosis lung environment: from the perspective of Pseudomonas aeruginosa. Curr Opin Pharmacol 65:102262. doi:10.1016/j.coph.2022.102262 - DOI - PubMed
    1. Cromwell EA, Ostrenga JS, Todd JV, Elbert A, Brown AW, Faro A, Goss CH, Marshall BC. 2023. Cystic fibrosis prevalence in the United States and participation in the cystic fibrosis foundation patient registry in 2020. J Cyst Fibros 22:436–442. doi:10.1016/j.jcf.2023.02.009 - DOI - PMC - PubMed
    1. Mahenthiralingam E, Campbell ME, Speert DP. 1994. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun 62:596–605. doi:10.1128/iai.62.2.596-605.1994 - DOI - PMC - PubMed
    1. Wolfgang MC, Jyot J, Goodman AL, Ramphal R, Lory S. 2004. Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients. Proc Natl Acad Sci U S A 101:6664–6668. doi:10.1073/pnas.0307553101 - DOI - PMC - PubMed

Substances